Early access: 15,549 bills from the current Congress so far, more added daily. Data from Congress.gov, GovInfo and the House and Senate vote records, updated Oct 13, 2026.
Public Law TrackerPLTPublic Law Tracker

H.R. 2541 · Where this bill is now

In committee

Introduced in the House, sent to the Committee on Energy and Commerce, Apr 1, 2025

What this bill does

In plain words · AI-written from the official summary

Nuclear medicine reporting rules get specific dose thresholds

When radioactive drugs used in medical treatments leak into tissue around blood vessels during injection, it's called an extravasation. Right now, the Nuclear Regulatory Commission has proposed making these incidents reportable events, but the reporting rule would be based on a doctor's judgment about whether injury might occur. This bill requires the NRC to instead set the reporting requirement using specific, measurable dose amounts that trigger the requirement to report.

How it affects you

This mainly affects hospitals and clinics that use radioactive drugs in medical imaging and treatment, along with the Nuclear Regulatory Commission that oversees them. The change gives these healthcare providers a clearer, more objective standard for when they must report these incidents, rather than relying on a physician's assessment of potential harm.

Read the official summary (Introduced in House, Apr 1, 2025)

Nuclear Medicine Clarification Act of 2025

This bill requires the Nuclear Regulatory Commission (NRC) to revise its regulations so that health care providers must report to the NRC when a dose of a radioactive drug caused by an extravasation exceeds specified quantities. An extravasation generally means the unintentional presence of a radioactive drug in the tissue surrounding the blood vessel following an injection.

Under the NRC’s current regulations, health care providers licensed by the NRC to use radioactive materials must submit a report to the NRC for any instance, known as a medical event, where the administered dose of a radioactive drug exceeds specified quantities or criteria.

In 2024, the NRC published a draft proposed rule that would add an extravasation as a medical event that must be reported. The draft proposed rule’s reporting threshold is based on a physician’s determination that the administration results or may potentially result in a radiation injury from an extravasation. The reporting threshold proposed by the NRC does not contain a quantified dose.

The bill requires the NRC to revise its regulations to add an extravasation as a medical event that must be reported, and it additionally requires the reporting threshold to be based on quantified doses (as specified in the bill).

Written by AI (Claude) using only the official summary by the Congressional Research Service, the Library of Congress’s nonpartisan research staff. It can miss nuance, so check the official summary and the bill text for details.

119th Congress
1st Session
H. R. 2541

A BILL

Nuclear Medicine Clarification Act of 2025

In the HouseNo vote yet

Sponsor: Rep. Donald G. Davis (D-NC-1) · Introduced Apr 1, 2025 · Health · 1 version of the text

Sources: Congress.gov actions and votes · bill text from GovInfo · latest official action Apr 1, 2025: “Referred to the House Committee on Energy and Commerce.”

Sections

Sections · 2